Meridian and International Medical Systems Sign Distribution Contract
Posted on: Thursday, 26 June 2008, 12:03 CDT
Meridian has signed an exclusive distribution contract with International Medical Systems for the Lapex 2000 LipoLaser in Latin America.
According to the agreement, International Medical Systems (IMS) will have the exclusive right to sell the Lapex 2000 LipoLaser in the following countries during the first phase of the contract: Brazil, Venezuela, Chile, Argentina, Uruguay, and Paraguay. The first year of the contract is based on projected sales of over $2.5 million.
Year two of the contract includes territory expansion to include, Central America, the Caribbean, Bolivia, Ecuador, and Peru with projected sales of over three million dollars. The third year of the contract, including all territory outlined above has projected sales of over four million. The initial contract is based on a purchase order of $135,000.
Juan Torres, president and co-founder of IMS, said: "We believe that our projections are relatively conservative as the Latin American market is ready for a completely non-invasive approach to spot fat reduction."
Source: Datamonitor
Related Articles
- Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 3rd Edition Report
- Rainmaker Renews and Expands Agreement With Fortune 500 Software Client for Contract Sales and Channel Support in Asia-Pacific
- Misonix Establishes New Contract Sales Organization for Distribution of SonicOne(TM) Wound Management System in the United Sates
- ReBuilder Medical Technologies, Inc. Increases Third Quarter Sales Projections By 75%; Anticipates Sales of $750,000
- PHA Commission Approves $25 Million for Construction Contracts and Projects
- PHA Commission Considers $25 Million for Construction Contracts and Projects
- PDI Announces New $23 Million Contract Sales Engagement With Top-Five Pharmaceutical Company
- Advancis Pharmaceutical Signs Contract Sales Agreement With Innovex
- NitroMed Announces Optimization of BiDil(R) Contract Sales Force
- Raleigh, N.C.-Based Drug Developer's Profit, Sales Projections Rise
User Comments (0)

RSS Feeds